{"id":"NCT00095173","sponsor":"Bristol-Myers Squibb","briefTitle":"BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis","officialTitle":"A Phase III, Multi-Center, Multi-National, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of BMS-188667 in Children and Adolescents With Active Polyarticular Juvenile Rheumatoid Arthritis (JRA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-12","primaryCompletion":"2006-06","completion":"2011-11","firstPosted":"2004-11-02","resultsPosted":"2017-01-18","lastUpdate":"2017-01-18"},"enrollment":214,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Juvenile Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":["Orencia"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Abatacept","otherNames":["Orencia"]}],"arms":[{"label":"Abatacept","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Abatacept - Open Label","type":"EXPERIMENTAL"}],"summary":"The primary purpose of the clinical research study is to assess the safety of treating children and juvenile subjects with BMS-188667 (Abatacept). In addition, the study will assess the effectiveness of BMS-188667 in reducing disease activity of Juvenile Rheumatoid Arthritis (JRA) or Juvenile Idiopathic Arthritis (JIA) as measured by the time to occurrence of disease flare.","primaryOutcome":{"measure":"Time to Occurrence of Juvenile Rheumatoid Arthritis/Juvenile Idiopathic Arthritis (JRA/JIA) Disease Flare During Double-Blind Phase (Period B)","timeFrame":"Period B (Day 113 to Day 282)","effectByArm":[{"arm":"Abatacept (Period B)","deltaMin":null,"sd":null},{"arm":"Placebo (Period B)","deltaMin":6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0002"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":36,"countries":["United States","Austria","Brazil","France","Germany","Italy","Mexico","Peru","Portugal","Spain","Switzerland"]},"refs":{"pmids":["37453737","37221146","36651601","33452173","26097215","20597110","20191582","18632147"],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":32},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Diarrhoea","Influenza"]}}